Hedy Teppler Selected Research

Pelvic Infection

01/2003	Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
11/2002	Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
01/2002	Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.

10	Infection 07/2008 - 01/2002
3	Pelvic Infection 01/2003 - 01/2002
1	Neutropenia 09/2004
1	Fever (Fevers) 09/2004
1	HIV Infections (HIV Infection) 05/2004
1	Sepsis (Septicemia) 07/2003
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2002

10	ertapenem (Invanz)FDA Link 08/2005 - 01/2002
7	Piperacillin FDA Link 08/2005 - 01/2002
7	tazobactamIBA 08/2005 - 01/2002
3	MK 0518 FDA Link 07/2008 - 10/2007
2	caspofungin (Cancidas)FDA Link 01/2006 - 09/2004
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 10/2007
1	liposomal amphotericin B FDA Link 09/2004
1	Interleukin-2 (IL2)IBA 05/2004
1	Metronidazole (Metric)FDA LinkGeneric 09/2002
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 09/2002
1	Thalidomide (Thalomid)FDA Link 05/2002